Urovist Meglumine Diu/ct

   
Google
 
Web NewDrugInformation.com

Urovist Meglumine Diu/ct


Drug - Urovist Meglumine Diu/ct
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Diatrizoate Meglumine
Multiple ingredients are in alphabetical order.

Strength - 30%
The potency of the active ingredient(s), Diatrizoate Meglumine. May repeat for multiple part products.

Applicant - BERLEX
The firm name holding legal responsibility for Urovist Meglumine Diu/ct. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 087739
The FDA assigned number to Urovist Meglumine Diu/ct. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Urovist Meglumine Diu/ct. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 23, 1982
The date Urovist Meglumine Diu/ct was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Urovist Meglumine Diu/ct. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Urovist Meglumine Diu/ct is in. Format is RX, OTC, DISCN.

Applicant Full Name - Berlex Inc
The full name of the firm holding legal responsibility for the new application of Urovist Meglumine Diu/ct.

Urovist Meglumine Diu/ct